MUHC research news
In his public lecture Dr. Mark Ware describes the most significant research developments and breakthroughs in the use of cannabis as a treatment for chronic pain.
According to new MUHC-led research, adolescent boys have a significantly increased risk of high systolic blood pressure (SBP) compared to adolescent girls.
Dr. Arthur Porter, Director General and CEO of the McGill University Health Centre (MUHC), is pleased to announce the appointment of Dr. Vassilios Papadopoulos as the new Director of the Research Institute of the MUHC.
New MUHC study adds more evidence to clear Measles Mumps Rubella vaccine as a risk factor for autism
The study, published in the scientific journal Pediatrics, reveals fundamental errors in previous molecular studies that falsely implicated the MMR vaccine as a risk factor for autism.
An opportunity for MUHC scientists to demystify their research, and for the public to meet the researchers and gain an inside look at some of the most exciting discoveries and innovative breakthroughs taking place right now on the cutting edge of science.
Breakthrough by MUHC researcher has major implications for diagnosis, treatment of childhood blindness
Eye Health Month is off to an exciting start, with the recent announcement by MUHC researcher Dr. Robert Koenekoop and his colleagues of a breakthrough discovery in the genetics of childhood blindness.
A new study conducted by MUHC researchers adds further evidence to the link between proton pump inhibitors, such as heartburn medications, and Clostridium difficile infection outside of hospitals.
A new breed of permanently "cheerful" mouse is providing hope of a new treatment for clinical depression. TREK-1 is a gene that can affect transmission of serotonin in the brain.
This innovative research, published in the journal Oncogene, is a significant step towards improving treatment for this devastating disease that kills more than two-thirds of people diagnosed.
A new MUHC study published today in the scientific journal Pediatrics assesses the link between childhood immunizations and PDD in 28,000 Quebec children and finally clears MMR vaccines and thimerosal-containing immunizations as risk factors.